Lamivudine API - 134678-17-4 Specificaton & Trade Terms
Model | 134678-17-4 |
---|
Place Of Origin | Tianjin,P.R.China |
---|
Packaging | barrel |
---|
Brand | Tianjin Sega Pharmaceutical Co.,Ltd |
---|
Certifications | GMP |
---|
Price Term | T/T |
---|
Payment Term | T/T |
---|
Supply Ability | 200000KG |
---|
Minimum Order | 10KG |
---|
Loading Ports | Tianjin,China |
---|
Delivery Time | 3days |
---|
Tianjin Sega Pharmaceutical Co.Ltd, belonging to TianJin Pharmaceutical Holdings(TJPH), is a wholly owned
subsidiary company of Tianjin Lisheng Pharmaceutical Co., Ltd. Sega invests 480 million RMB(70 million USD) to
construct its APIs manufacturing site, which covers 199 thousand sq meters.As a professional pharmaceutical
company, Sega dedicates itself to improving people’s health, providing high-quality pharmaceutical products and
relevant service to human being. It applies the latest state of the art technology to manufacture APIs. To ensure the
production of high-quality pharmaceuticals, the facilities are built and administered according to the ICH Q7A and
cGMP standard strictly, aiming to make itself approved by the the pharmaceutical administration of the regulatory
market, such as US FDA, EDQM, PMDA etc..
Product Name : Lamivudine
Specification : USP32
Cas No. 134678-17-4
99%